Effective on trade date Friday, October 7, 2022, and pending all relevant CFTC regulatory review periods, this Market Regulation Advisory will supersede CME Group Market Regulation Advisory Notice RA2117-5 from September 29, 2021. It is being issued in connection with CFTC Letter No. 22-09 No-Action, dated August 10, 2022, extending no-action relief from certain aggregation requirements except in a situation where such person holds or controls the trading of such positions in order to willfully circumvent applicable position limits.
Click HERE to view the full advisory.